Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Z - Cancer Care Old > Breast Cancer (AAG) > Flashcards

Breast Cancer (AAG) Flashcards

1
Q

How common is breast cancer?

A

It is the second most frequent cancer in women, after non-melanotic skin cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does breast cancer compare to other diseases in terms of causing death?

A

It is the most common cause of death in women aged 35-54 years in England

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the typical course of breast cancer

A

It follows an unpredictable cause, with metastases presenting up to 20 years after initial diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the life time risk of breast cancer in the England?

A

1 in 9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What has caused improvements in the 5 year survival of breast cancer?

A
  • Earlier detection by screening

- Improved treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What factors play a role in the aetiology of breast cancer?

A
  • Genetic factors

- Hormonal factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In what % of breast cancer cases is hereditary predisposition implicated?

A

Around 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give 3 examples of hereditary disposition of breast cancer

A
  • BRCA1 mutation
  • BRCA2 mutation
  • Li-Fraumeni syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What hormonal factors are important in the development of breast cancer?

A

Prolonged exposure to oestrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What can cause a prolonged exposure to oestrogen?

A
  • Early menarche
  • Late menopause
  • Late first pregnancy (over 35 years old)
  • Nulliparity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Does the OCP increase the relative risk of breast cancer?

A

Not significantly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Does HRT increase the relative risk of breast cancer?

A

Yes, in long-term current users

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the most common histology of breast cancer?

A

Invasive ductal carcinoma, with or without ductal carcinoma in situ (DCIS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What % of cases of breast cancer are invasive ductal carcinoma?

A

70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the second most common type of breast cancer histology?

A

Invasive lobular carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What % of screening-detected breast cancers are DCIS?

A

20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

In what proportion of women is DCIS multi-focal?

A

1/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the risk of DCIS becoming invasive?

A

High - 10% at 5 years following excision only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Does pure DCIS cause lymph node metastases?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the clinical significance of lobular carcinoma in situ?

A

It is a predisposing risk factor for developing cancer in either breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the risk of developing breast cancer in a patient with lobular carcinoma in situ?

A

7% at 10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How does breast cancer usually present?

A

As a mass that persists throughout the menstrual cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What % of patients with breast cancer have nipple discharge?

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What % of patients with breast cancer have pain?

A

7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Give an example of a presentation that confers an adverse prognosis in breast cancer

A

Inflammatory carcinomas with diffuse induration of the skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How are women with breast cancer increasingly presenting?

A

As a consequence of mammographic screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What % of breast cancer patients will have axillary nodal disease?

A

40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What increases the likelihood of breast cancer patients having axillary nodal disease?

A

Increasing size of the primary tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the strongest prognostic predictor in breast cancer?

A

The involvement of axillary nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Are distant metastases commonly present at time of diagnosis?

A

No, it is infrequent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the most common sites of spread of breast cancer?

A
  • Bone
  • Lung
  • Liver
  • Pleura
  • Adrenals
  • Skin
  • Brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What % of breast cancer cases does Paget’s disease of the nipple account for?

A

1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

How does Paget’s disease of the nipple present?

A

With a relatively long history of eczematous change in the nipple area, with itching, burning, oozing, or bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Is there a palpable underlying lump in Paget’s disease of the nipple?

A

There may be

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What does the nipple contain in Paget’s disease of the nipple?

A

Malignant cells, singularly or in nests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is prognosis related to in Paget’s disease of the nipple?

A

The underlying tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What should be looked for on the face in breast cancer?

A
  • Conjunctival pallor

- Jaundice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What lymph node areas may be involved in breast cancer?

A
  • Neck
  • Supraclavicular
  • Axillary
39
Q

What may be found on breast examination in breast cancer?

A
  • Asymmetry
  • Mass
  • Overlying skin changes
  • Peau d’orange
  • Displacement of nipples
  • Nipple inversion or retraction
  • Nipple discharge
  • Inflammatory changes
  • Puckering
  • Discolouration
  • Change in temperature
40
Q

What should be done with any mass on breast examination?

A

Measure it

41
Q

What may be seen on observation in breast cancer

A
  • Skin changes
  • Ascites
  • Cachexia
  • Dehydration
  • Previous radiotherapy marks
42
Q

What should be looked for on the hands in breast cancer?

A
  • Signs of smoking
  • Pallor
  • Lymphoedema
43
Q

What should be looked for in the periphery in breast cancer?

A

Calf tenderness or DVT

44
Q

What might be seen on fundoscopy in breast cancer?

A

Choroidal metastasis

45
Q

What should be looked for on cardiovascular examination in breast cancer?

A
  • Atrial fibrillation

- Pericardial effusion

46
Q

What should be looked for on respiratory examination in breast cancer?

A
  • Consolidation

- Pleural effusion

47
Q

What should be looked for on abdominal examination in breast cancer?

A
  • Abdominal distention
  • Ascites
  • Hepatomegaly
48
Q

What should be looked for on neurological examination in breast cancer?

A
  • Focal neurological signs
  • Sensory deficit
  • Spinal cord compression
  • Memory deficit
  • Personality change
  • Cranial nerve changes
49
Q

What features of hypercalcaemia may be seen in breast cancer?

A
  • Confusion
  • Nausea
  • Polydipsia
50
Q

What should be looked for on skeletal examination in breast cancer?

A
  • Focal bone tenderness

- Vertebral collapse

51
Q

Where should be checked for focal bone tenderness in breast cancer?

A
  • Pelvis
  • Spine
  • Humerus
  • Femur
52
Q

What is T0 in breast cancer?

A

No evidence of primary tumour

53
Q

What is T1 in breast cancer?

A

Tumour of 2cm or less in its greatest dimension

54
Q

What differentiates T1a and T1b in breast cancer?

A

T1a has no fixation to underlying pectoral muscle or fascia, whereas T1b does.

55
Q

What is T2 in breast cancer?

A

Tumour more than 2cm, but not more than 5cm in its greatest dimension

56
Q

What is T3 in breast cancer?

A

Tumour more than 5cm in its greatest dimension

57
Q

What differentiates between T3a and T3b in breast cancer?

A

T3a has no fixation to underlying pectoral muscle and fascia, T3b does

58
Q

What is T4 in breast cancer?

A

Tumour of any size fixed with direct extension to the chest wall and skin

59
Q

What is meant by ‘chest wall’ when staging breast cancer?

A
  • Ribs
  • Intercostal muscles
  • Serratus anterior muscle

Not pectoral muscle

60
Q

What is N0 in breast cancer?

A

No ipsilateral lymph node metastasis

61
Q

What is N1 in breast cancer?

A

Movable ipsilateral axillary nodes

62
Q

What differentiates N1a and N1b in breast cancer?

A

In N1a, the nodes are not considered to contain growth. In N1b, they are considered to contain growth

63
Q

What is N2 in breast cancer?

A

Ipsilateral axillary nodes containing growth, and fixed to one another or to other structures

64
Q

What is N3 in breast cancer?

A

Ipsilateral supraclavicular or infraclavicular nodes containing growth or oedema of the arm

65
Q

What is M0 in breast cancer?

A

No distant metastasis

66
Q

What is M1 in breast cancer?

A

Distant metastasis, including skin involvement beyond the breast area

67
Q

What are the treatment options for LCIS?

A

Span from observation with annual screening, to bilateral prophylactic mastectomy in selected patients

68
Q

Is there a place for chemotherapy in LCIS or DCIS?

A

No

69
Q

What is the treatment for patients with early breast cancer?

A

Wide local excision and axillary node surgery, followed by adjuvant breast radiotherapy

70
Q

What axillary node surgery might be done in patients with early breast cancer?

A
  • Dissection
  • Sampling
  • Sentinel lymph node biopsy
71
Q

What is the advantage of wide local excision and radiotherapy over mastectomy in early breast cancer?

A

It achieves similar local control and survival rates to mastectomy, with less mutilating surgery

72
Q

What is the purpose of adjuvant radiotherapy in early breast cancer?

A

It is given to reduce the risk of local recurrence

73
Q

By how much does post-operative radiotherapy reduce the recurrence in early breast cancer?

A

Reduces rate from 40-60% to 4-6%

74
Q

What drugs are used for adjuvant hormonal therapy in breast cancer?

A
  • Tamoxifen

- Aromatase inhibitors

75
Q

What is the advantage of adjuvant hormonal therapy in breast cancer?

A

It can improve disease-free and overall survival in pre- and post-menopausal patients who have tumours that express oestrogen receptors

76
Q

Who will only require adjuvant hormonal therapy?

A

Patients at low risk, with tumours that are small and ER +ve

77
Q

What hormonal therapy should be given to ER +ve breast cancer patients that are pre-menopausal?

A

LHRH analogue

78
Q

What hormonal therapy should be given to ER +ve breast cancer patients that are post-menopausal?

A

Tamoxifen and an aromatase inhibitor

79
Q

Who should adjuvant chemotherapy be considered for?

A

Patients at higher risk of recurence

80
Q

What factors increase the risk of recurrence in breast cancer?

A
  • Tumour >1cm
  • Tumour that is ER -ve
  • Involvement of axillary lymph nodes
81
Q

What is the advantage of adjuvant chemotherapy in breast cancer patients at higher risk of recurrence?

A

It improves disease-free and overall survival

82
Q

What is trastuzumab?

A

A humanised monoclonal antibody to HER2

83
Q

What is the use of trastuzumab?

A

It should be used alongside standard chemotherapy in women with early HER2+ breast cancer

84
Q

What is the aim of breast cancer treatment, with respect to receptor status?

A

To personalise the treatment approach depending on the patients receptor status, including ER +, HER2+, and ER/PR/HER ‘triple negative’ patients

85
Q

Why is important to personalise the breast cancer treatment approach based on receptor status?

A

Because the clinico-pathological behaviour of these groups of patients is distinct, and they require appropriate treatment strategies to optimise the survival benefit of adjuvant treatment

86
Q

What endocrine therapy is used in metastatic breast cancer?

A

Second line endocrine therapy with aromatase inhibitors

87
Q

What is the purpose of aromatase inhibitors in metastatic breast cancer?

A

They inhibit peripheral oestrogen production in adrenal and adipose tissues

88
Q

How might advanced ER -ve breast cancer be traeted>

A

With combination chemotherapy

89
Q

What might be considered for patients with relapsed HER2+ disease?

A

Trastuzumab

90
Q

What is involved in the treatment of bone metastases in breast cancer?

A
  • Radiotherapy

- Bisphosphonates

91
Q

What is the purpose of radiotherapy in bone metastases?

A

Pallitation to reduce pain

92
Q

What is the purpose of bisphosphonates in bone metastases?

A
  • Treat hypercalcaemia

- Reduce skeletal morbidity

93
Q

Is tamoxifen effective in the chemoprevention of breat cancer?

A

It has been shown to reduce the incidence of breast cancer in an American RCT in women with high risk of developing breast cancer, but the results have not been reproduced in similar European trials

Z - Cancer Care Old (28 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions